Cresco Labs, Inc. (CRLBF)
0.8802
+0.06
(+7.25%)
USD |
OTCM |
May 20, 15:59
Cresco Labs EPS Diluted (Quarterly) : -0.0359 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 0.4151 |
| MariMed, Inc. | -0.0095 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.01M |
| Revenue (Quarterly) | 151.32M |
| Total Expenses (Quarterly) | 164.40M |
| Enterprise Value | 735.46M |
| Gross Profit Margin (Quarterly) | 46.61% |
| Profit Margin (Quarterly) | -11.24% |
| Earnings Yield | -42.41% |
| Operating Earnings Yield | 29.03% |
| Normalized Earnings Yield | -11.82 |